I doubt it. They only had a profit of $250k for 2018...they aren't going to show a huge increase as they are reinvesting into marketing and their brand...I would say $350k-$400k should be reasonable if they pullback their marketing spend rate for second half of the year. They only netted $51k for Q1. As their marketing spend decreases along with more favorable COGS due to increase of quantities we will see a nice uptick in profit.
They are spending their capital wisely and reinvesting to build their brand which will increase shareholder value over time.
The doors will blow off this whole space once FDA stuff is finalized. Should be an interesting second half of the year.
News 
Market Data 
Discover 
